FDA’s priority review gives opioid-overdose reversal drug expected approval date of March 2023, company says

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Dunkin’ to Be Sold to Inspire Brands for $8.8 Billion

Inspire Brands Inc. will buy Dunkin’ Brands Group Inc. for $8.8 billion,…

A city of 710,000 struggles to cope with 40,000 migrant arrivals

Nearly 40,000 migrants have arrived in Denver over the past year, making…

FAA says it’s investigating Boeing for 787 Dreamliner issue

IE 11 is not supported. For an optimal experience visit our site…

Huge video screen falls onto stage during concert in Hong Kong, injuring 2 dancers

HONG KONG — Two male dancers have been injured after a huge…